BioSpace News Archive

Deals

Centene Receives Regulatory Approval For The Fidelis Care Transaction From New York Department Of Health And New York Department Of Financial Services

September 12, 2017, Centene Corporation and Fidelis Care entered into an Asset Purchase Agreement

April 23, 2018

·

10 min read

Business

Porton Pharma Solutions and Codexis Launch Global Partnership

Partnership will accelerate the creation and commercialization of new, low-cost, sustainable manufacturing processes, exploiting the benefits of biocatalysts to a growing number of the world’s small molecule pharmaceuticals.

April 23, 2018

·

6 min read

Business

Innovus Pharma Expands its Senior Management with the Addition of Ryan Selhorn, CPA, as its Vice President, Chief Financial Officer

Industry Veteran to Lead Company’s Financial and Accounting Operations into its Expanding Revenue Growth Stage

April 23, 2018

·

4 min read

Lone Star Bio

DecisionDx-Melanoma Test Independently Improved Identification of High-Risk Patients Compared to AJCC Staging in Stage I-II Cutaneous Melanoma

Posters presented at the Real World Dermatology for Physician Assistants and Nurse Practitioners conference also include data demonstrating test’s clinical utility

April 23, 2018

·

5 min read

FDA

MeiraGTx Announces AAV-RPGR Granted Fast Track Designation by U.S. FDA for Treatment of X-Linked Retinitis Pigmentosa Due to RPGR Deficiency

MeiraGTx Limited, a vertically integrated, clinical stage gene therapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for AAV-RPGR for the treatment of X-linked retinitis pigmentosa (XLRP) due to defects in the retinitis pigmentosa GTPase regulator (RPGR) gene.

April 23, 2018

·

3 min read

Business

CBT Pharmaceuticals and CrystalGenomics Announce Partnership for Co-development of Global Immuno-Oncology Therapy

CBT Pharmaceuticals (CBT) and CrystalGenomics, Inc., (KOSDAQ:083790) today announced a co-development agreement for an investigational combination therapy of CBT-501 and CG200745 across a variety of solid tumors with high unmet medical needs.

April 23, 2018

·

4 min read

FDA

Pfizer Granted FDA Breakthrough Therapy Designation for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Children Ages 1 to 9 Years

This is the first Breakthrough Therapy designation for a MenB vaccine to help protect children as young as 1 year of age.

April 23, 2018

·

9 min read

FDA

Amerigen and Dipharma Announce U.S. FDA Approval for Generic Miglustat 100 mg Capsules

The first generic version of Miglustat is now approved in the U.S.

April 23, 2018

·

3 min read

Genetown

Glutenostics Announces Clinical Studies at Harvard Hospitals Focused on At-Home Gluten Detection Technology

Glutenostics LLC, today announced plans for two important clinical studies involving “Gluten Detective” technology, the first at-home product designed to monitor gluten consumption, to help people on a gluten-free diet maintain compliance.

April 23, 2018

·

3 min read

Pharm Country

Regeneron Announces Upcoming Investor Conference Presentations

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations

April 23, 2018

·

1 min read